Holen Sie sich die Stockscreener-App
1.45
0.00%
0.00
Pliant Therapeutics Inc Aktie (PLRX) Neueste Nachrichten
Relative strength of Pliant Therapeutics Inc. in sector analysis2025 Macro Impact & Low Drawdown Investment Strategies - Newser
Has Pliant Therapeutics Inc. formed a bullish divergence2025 EndofYear Setup & Proven Capital Preservation Methods - Newser
Will Pliant Therapeutics Inc. stock split in the near futureExit Point & Momentum Based Trading Ideas - Newser
Will Pliant Therapeutics Inc. price bounce be sustainableMarket Sentiment Review & Technical Entry and Exit Alerts - Newser
Using Ichimoku Cloud for Pliant Therapeutics Inc. technicalsWeekly Trend Report & Free Growth Oriented Trading Recommendations - Newser
What recovery options are there for Pliant Therapeutics Inc.Bull Run & Low Drawdown Investment Ideas - Newser
What makes Pliant Therapeutics Inc. stock price move sharplyWeekly Trade Review & Free High Accuracy Swing Entry Alerts - Newser
Backtesting results for Pliant Therapeutics Inc. trading strategiesGlobal Markets & AI Driven Price Predictions - Newser
How to recover losses in Pliant Therapeutics Inc. stockJuly 2025 Levels & Smart Allocation Stock Tips - Newser
Ranking Pliant Therapeutics Inc. among high performing stocks via toolsPortfolio Gains Report & Consistent Profit Trade Alerts - Newser
Is now a turning point for Pliant Therapeutics Inc.July 2025 Chart Watch & High Accuracy Investment Entry Signals - Newser
Will Pliant Therapeutics Inc. Sustain Its Chart BreakoutPortfolio Return Report & Weekly High Conviction Ideas - beatles.ru
Using Bollinger Bands to evaluate Pliant Therapeutics Inc.CEO Change & Accurate Intraday Trade Tips - Newser
Pliant Therapeutics Inc. Stock Chart Analysis: Bullish or Bearish Pattern FormingJuly 2025 Decliners & Breakout Confirmation Alerts - Newser
Short Interest Drops in Pliant Therapeutics Inc. After Rally2025 Support & Resistance & Growth Focused Stock Reports - newsyoung.net
Is Pliant Therapeutics Inc. currently under institutional pressureJuly 2025 Sector Moves & Verified Momentum Stock Ideas - metrotimes.co.kr
Pliant Therapeutics Reports Q2 2025 Financial Results - TipRanks
Is Pliant Therapeutics Inc. a defensive stockMarket Volume Summary & Free High Accuracy Swing Entry Alerts - thegnnews.com
Citi Maintains Pliant Therapeutics(PLRX.US) With Hold Rating, Maintains Target Price $1.7 - 富途牛牛
How to manage a losing position in Pliant Therapeutics Inc.High Return Trade Roadmap with Setup Filters - Newser
Citi Raises Pliant Therapeutics Price Target to $1.70 Amid Unclear Path Forward - AInvest
Healthcare Sector Analysts Weigh In on Sangamo Biosciences, Pliant Therapeutics, and Zimmer Biomet Holdings - AInvest
Citi Reaffirms Their Hold Rating on Pliant Therapeutics (PLRX) - The Globe and Mail
A Quick Look at Today's Ratings for Pliant Therapeutics(PLRX.US), With a Forecast Between $1.7 to $4 - 富途牛牛
Pliant Therapeutics Pivots To Oncology After Ending IPF Program - Finimize
Pliant Therapeutics shares fall 1.25% intraday after workforce realignment and BEACON-IPF closure. - AInvest
RBC Capital Maintains Pliant Therapeutics(PLRX.US) With Hold Rating, Maintains Target Price $3 - 富途牛牛
Pliant Therapeutics stock price target slashed by Piper Sandler - Investing.com Canada
Needham Maintains Pliant Therapeutics(PLRX.US) With Hold Rating - 富途牛牛
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results - 富途牛牛
Pliant Therapeutics Inc reports results for the quarter ended June 30Earnings Summary - TradingView
Pliant Therapeutics reports Q2 EPS (71c), consensus (68c) - TipRanks
Pliant Therapeutics Q2 net loss narrows - MarketScreener
Pliant Therapeutics reports Q2 FY25 financial results, Phase 1 oncology trial on track. - AInvest
Pliant Therapeutics shares rise 2.65% intraday after IDEAYA Biosciences reports positive Phase 2/3 trial data. - AInvest
Should I hold or sell Pliant Therapeutics Inc. stock in 2025Tremendous financial leverage - Jammu Links News
Pliant Therapeutics Inc. Stock Analysis and ForecastRapidly expanding wealth - Jammu Links News
How many analysts rate Pliant Therapeutics Inc. as a “Buy”Identify undervalued stocks ready to soar - Jammu Links News
A Quick Look at Today's Ratings for Pliant Therapeutics(PLRX.US), With a Forecast Between $3 to $17 - 富途牛牛
How volatile is Pliant Therapeutics Inc. stock compared to the marketDiscover hidden gems in the stock market - Jammu Links News
How does Pliant Therapeutics Inc. compare to its industry peersInvest confidently with market-leading analysis - Jammu Links News
Is Pliant Therapeutics Inc. a good long term investmentInvest confidently with expert support - Jammu Links News
Does Pliant Therapeutics Inc. stock perform well during market downturnsAchieve rapid portfolio growth with expert guidance - Jammu Links News
What is the risk reward ratio of investing in Pliant Therapeutics Inc. stockGame-changing returns - Jammu Links News
What are Pliant Therapeutics Inc. company’s key revenue driversDiscover undervalued opportunities early - Jammu Links News
What is Pliant Therapeutics Inc. company’s growth strategyBuild wealth steadily with smart stock selection - Jammu Links News
Pliant Therapeutics Inc. Trading Near Value Zone — Recovery AheadTop Performing Stock Insights Released Daily - metal.it
0.94%
1.72%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):